about
A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease.Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils.Top-down study of β2-microglobulin deamidationEstimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney diseaseComparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol.Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease.Proteomic analyses of human plasma: Venus versus Mars.The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator.Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.Skin Mucus of Gilthead Sea Bream (Sparus aurata L.). Protein Mapping and Regulation in Chronically Stressed FishRenal amyloidosis in children.Pathophysiology and treatment of systemic amyloidosis.Nephro-oncology: a link in evolution.Role of β2-microglobulin in postoperative cognitive decline.Evaluation of salivary beta-2 microglobulin as HBV proliferation marker in HBS Ag(+), HBV DNA PCR(+) and HBV DNA PCR(-) subjects.A regional blood flow model for β2-microglobulin kinetics and for simulating intra-dialytic exercise effect.The Relationship between Salivary Beta-2 Microglobulin and Uremia Intensity in Men with Chronic Renal Failure.β2-microglobulin gene duplication in cetartiodactyla remains intact only in pigs and possibly confers selective advantage to the species.Tumour markers and kidney function: a systematic review.Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issues.Why are Functional Amyloids Non-Toxic in Humans?Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Using Covalent Labeling and Mass Spectrometry To Study Protein Binding Sites of Amyloid Inhibiting Molecules.Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
P2860
Q33990550-9E636A4A-2527-4E19-AF2B-8C8C8D822AA1Q34077850-B426C327-E043-4285-BB5F-D4F4887BE833Q34219743-76F12F9E-FAA3-4721-84A1-F093418A4F44Q34406428-86FD8FAD-FE07-4B65-A29A-E2210A34CA1AQ34487256-7632CA4F-BB39-4861-832A-11361F97BCEAQ35089837-4EB9F6C1-4777-48DD-AC58-610BD04A9284Q35605878-9FEBAC1A-D67A-4899-80CB-E873B93C059CQ36709380-63A1B173-E923-4295-9522-8A9E86D537FCQ36849928-A069E67A-F746-469D-9C6D-E34E41BEBDF0Q37620736-4874E173-0C58-47FD-B7D0-0145B31B7332Q37848210-00461EB2-9AC5-4B3B-944A-15953D7B71CFQ38131710-F9AD998C-D4D5-4012-AB72-B606369A54A9Q38554467-64A13EF0-BF1C-4D64-8460-B4FA3C2A05CBQ38940351-03DE7E74-16C8-4FA7-81A5-48A7D23935C6Q39492949-30A244AD-FEA2-48E5-B7C5-324A56BF1A24Q39713068-7BA620E4-7E85-4BB2-98B2-B2152CF20409Q41325555-79C36699-4297-4D74-BE15-DAAABAF0B08CQ41433006-FC573B8F-1B0E-46AB-AA0E-D48B30FE0909Q41858828-9258BAAE-30BE-4DA1-869B-C3395E631D7FQ43198340-DB44CA05-BC83-4930-BBB2-60D0311B0964Q46302841-70DDF10D-B342-4B30-AC04-9695A0F2F8BFQ46372407-E8284A41-FE32-40E8-A6C9-50C4A09E676FQ47216784-BAD1F45F-B548-4C72-AB99-B74D604AC23EQ47657947-67CAE19A-AC5E-45FE-B960-86F2CB873A55Q51331971-EEF79DE4-2F8E-444E-A345-E87B0863BA70
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta2-microglobulin.
@en
Beta2-microglobulin.
@nl
type
label
Beta2-microglobulin.
@en
Beta2-microglobulin.
@nl
prefLabel
Beta2-microglobulin.
@en
Beta2-microglobulin.
@nl
P1433
P1476
Beta2-microglobulin.
@en
P2093
Tilman B Drüeke
Ziad A Massy
P2860
P304
P356
10.1111/J.1525-139X.2009.00584.X
P577
2009-07-01T00:00:00Z